Kyoto University researchers have regenerated neural stem cells in an adult mouse and improved its cognitive function through its method, dubbed "iPaD."
The test results were equivalent to turning a 60-year-old-human's neural stem cells into those of a teenager.
However, there are challenges in applying the procedure to humans because the mouse’s genetic engineering involved using a virus to inject the genes into the brain.
The research team’s leader, visiting professor Ryoichiro Kageyama, said they would continue to see if the procedure can be applied to humans.
The team will now test its iPaD method on marmosets to determine if its applicability to primates.
The ability to multiply embryonic neural stem cells to increase the number of nerve cells weakens with age. That, in turn, results in reduced cognitive function.
The iPaD method maximizes the activation of the neural stem cells by combining the infant mice’s most active genes with a restraining function of the adult mice’s most active genes.
The engineered neural stem cells in an adult mouse became more active with the neural stem cells continuing to multiply for about three months.
|Consequently, the adult mouse improved its cognitive function with the increase in neural stem cell multiplication.


Google Revamps EU Search Results to Meet DMA Rules
ECB Rate Hike in Focus as Oil Tops $100
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
UK Food Inflation Forecast to Hit 6.4% by Mid-2027
Neuralink Expands Brain Implant Trials with 12 Global Patients
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Oil Prices Surge as Middle East Shipping Attacks Threaten Supply
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
UK Economy Grows 0.4% in July, Beating Forecasts
Asian Stocks Fall as Oil Tops $100, Yields Rise
Kioxia Rules Out SK Hynix Manufacturing Partnership
Asian Currencies Steady as Yen Holds Firm, Oil Tops $100
White House Weighs Refined Copper Tariffs as Cost Concerns Grow
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows
OpenAI Rules Out 2026 IPO as Altman Prioritizes AI Safety 



